Upjohn

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

Upjohn

Hoeilaart ·KBO/BCE: BE 0552.558.025

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility Decision tools Company map

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Developers Badge Business information compared Free company information

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Your question travels, with the dossier's public data, to our AI model at Anthropic in the US. Nothing that identifies you goes along, and we keep neither question nor answer. Answers can be wrong, so this is not legal advice. How it works

Metric	This company	Sector median	Position in the sector
Solvency	96.0%	46.9%	better than 95% of 46 sector peers
Net result	€781k	€-1k	better than 95% of 46 sector peers
Equity	€11.25M	€108k	better than 91% of 46 sector peers
Total assets	€11.72M	€284k	better than 90% of 46 sector peers

Fiscal year	2024
Revenue	-
EBITDA	-
Net profit	€781k
Cash flow	-
Staff costs	€2k
Income taxes	€303k
Dividends	-
Total assets	€11.72M
Equity	€11.25M
Debt	€469k
of which ≤ 1y	€469k
of which > 1y	-
Working capital	€11.25M
Employees (FTE)	-

	2024
Current ratio	24.98
Quick ratio	24.98
Working capital ratio	96.0%
Solvency	96.0%
Debt / equity	0.04
Long-term debt ratio	-
Interest coverage	-
Gross margin	-
Net margin	-
ROA	6.7%
ROE	6.9%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€11.72M
Fixed assets	21/28	€0
Intangible fixed assets	21	€0
Current assets	29/58	€11.72M
Amounts receivable within one year	40/41	€11.54M
Cash & bank	54/58	€172k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€11.72M
Equity	10/15	€11.25M
Contributions / capital	10/11	€6.44M
Reserves	13	€1.26M
Accumulated profits (losses)	14	€3.55M
Amounts payable	17/49	€469k
Amounts payable within one year	42/48	€469k
Trade debts payable within one year	44	€253k
Income statement
Operating result	9901	€730k
Financial income	75	€360k
Financial charges	65	€6k
Result before taxes	9903	€1.08M
Income taxes	67/77	€303k
Net result for the period	9904	€781k
Result to be appropriated	9905	€781k

Statutory auditor	IRE/IBR number	Tenure
Deloitte Réviseurs d’Entreprises SCRLCurrent Company auditor · represented by Gert Vanhees	-	28-10-2022 → present
Klynveld Peat Marwick Goerdeler- Réviseurs d'Entreprises Company auditor · represented by Patrick Simons succeeded by Deloitte Réviseurs d’Entreprises SCRL in 2022	-	01-12-2014 → 28-10-2022
KPMG Réviseurs d'Entreprises SCRL civile Statutory auditor · represented by Patrick Simons	-	- → 01-10-2017

Summary

Conclusion

Signals

Trust signals

Administrative Flags

Bankruptcy probability (12 mo)

Financials

Annual accounts & ratios

Health barometer

Directors

Directors & mandates

Statutory auditor

Insolvency mandates

Legal Structure

Structure & network

Connections & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Publications

Lifecycle & Insolvency Signals

Belgisch Staatsblad · acts

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)

NACE primary	Vervaardiging van geneesmiddelen(21201)
Legal form	Private limited company(610)
Incorporation	09-05-2014
Status	Active
Postal code	1560

Parcel (capakey)	Region	Area	Buildings	Height / fl.
23033C0075/00L019	Flanders	3,821 m²	1 · 921 m²	14.7 m · 4 fl.
23033C0073/00E009	Flanders	1,970 m²	1 · 173 m²	15.2 m · 2 fl.